1. Home
  2. CASH vs AMPH Comparison

CASH vs AMPH Comparison

Compare CASH & AMPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASH
  • AMPH
  • Stock Information
  • Founded
  • CASH 1954
  • AMPH 1996
  • Country
  • CASH United States
  • AMPH United States
  • Employees
  • CASH N/A
  • AMPH N/A
  • Industry
  • CASH Major Banks
  • AMPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • CASH Finance
  • AMPH Health Care
  • Exchange
  • CASH Nasdaq
  • AMPH Nasdaq
  • Market Cap
  • CASH 1.8B
  • AMPH 1.7B
  • IPO Year
  • CASH N/A
  • AMPH 2014
  • Fundamental
  • Price
  • CASH $77.74
  • AMPH $35.70
  • Analyst Decision
  • CASH Hold
  • AMPH Buy
  • Analyst Count
  • CASH 3
  • AMPH 4
  • Target Price
  • CASH $80.67
  • AMPH $60.33
  • AVG Volume (30 Days)
  • CASH 206.9K
  • AMPH 713.7K
  • Earning Date
  • CASH 01-21-2025
  • AMPH 02-26-2025
  • Dividend Yield
  • CASH 0.26%
  • AMPH N/A
  • EPS Growth
  • CASH 10.58
  • AMPH 17.38
  • EPS
  • CASH 6.62
  • AMPH 3.01
  • Revenue
  • CASH $711,045,000.00
  • AMPH $723,549,000.00
  • Revenue This Year
  • CASH N/A
  • AMPH $16.76
  • Revenue Next Year
  • CASH $5.10
  • AMPH $8.00
  • P/E Ratio
  • CASH $11.74
  • AMPH $11.86
  • Revenue Growth
  • CASH 10.44
  • AMPH 20.33
  • 52 Week Low
  • CASH $46.68
  • AMPH $34.60
  • 52 Week High
  • CASH $86.00
  • AMPH $56.88
  • Technical
  • Relative Strength Index (RSI)
  • CASH 55.51
  • AMPH 34.11
  • Support Level
  • CASH $76.39
  • AMPH $34.60
  • Resistance Level
  • CASH $77.84
  • AMPH $39.01
  • Average True Range (ATR)
  • CASH 1.85
  • AMPH 1.53
  • MACD
  • CASH 0.56
  • AMPH 0.20
  • Stochastic Oscillator
  • CASH 93.28
  • AMPH 24.94

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

About AMPH Amphastar Pharmaceuticals Inc.

Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Share on Social Networks: